Abstract
Purpose
After cancer treatment, it is desirable to maintain or regain a high quality of life (QoL) and the ability to accomplish everyday tasks well. Therefore, we substantiated the scarce knowledge regarding long-term QoL after breast cancer, burdensome problems, and unmet needs for more support.
Methods
Disease-free breast cancer survivors (n = 190) who had participated in two randomized controlled exercise trials during primary treatment were followed up to 5 years post-diagnosis. QoL-related functions and symptoms (EORTC QLQ-C30/-BR23), health problems, and support needs were assessed. EORTC-QLQ scores were compared with age-matched normative values from the general population in Germany.
Results
QoL-related functions and symptoms in patients during cancer treatment were worse compared to healthy references, but largely improved over time. Yet, cognitive function and sleep were still significantly impaired at 5-year follow-up. Other common long-term problems included sexual issues (45% of survivors), hot flashes (38%), pain (34%), fatigue (24%), and polyneuropathy (21%). Regression analyses indicated fatigue having the strongest impact on global QoL. Support needs were expressed mainly for menopausal disorders (43%), physical performance (39%), sleep problems (38%), arthralgia (37%), cognitive problems (36%), weight problems (32%), and fatigue (31%).
Conclusions
While QoL in disease-free breast cancer survivors 5 years post-diagnosis was largely comparable to the general population on average, still many survivors suffered from adverse effects. There appears to be a need for ongoing screening and support regarding fatigue, sleep problems, cognitive problems, arthralgia/pain, menopausal/sexual symptoms, physical performance, and weight problems during and several years following breast cancer therapy.
Similar content being viewed by others
References
American Cancer Society. (2016). Cancer treatment & survivorship facts & figuress. 2016-2017. Atlanta: American Cancer Society.
Aubin, M., Giguere, A., Martin, M., Verreault, R., Fitch, M. I., Kazanjian, A., et al. (2012). Interventions to improve continuity of care in the follow-up of patients with cancer. The Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD007672.
Nyarko, E., Metz, J. M., Nguyen, G. T., Hampshire, M. K., Jacobs, L. A., & Mao, J. J. (2015). Cancer survivors’ perspectives on delivery of survivorship care by primary care physicians: An internet-based survey. BMC Family Practice, 16, 143. https://doi.org/10.1186/s12875-015-0367-x.
Mao, J. J., Bowman, M. A., Stricker, C. T., DeMichele, A., Jacobs, L., Chan, D., et al. (2009). Delivery of survivorship care by primary care physicians: The perspective of breast cancer patients. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 27(6), 933–938. https://doi.org/10.1200/JCO.2008.18.0679.
Berger, A. M., Mitchell, S. A., Jacobsen, P. B., & Pirl, W. F. (2015). Screening, evaluation, and management of cancer-related fatigue: Ready for implementation to practice? CA: A Cancer Journal for Clinicians, 65(3), 190–211. https://doi.org/10.3322/caac.21268.
Selamat, M. H., Loh, S. Y., Mackenzie, L., & Vardy, J. (2014). Chemobrain experienced by breast cancer survivors: A meta-ethnography study investigating research and care implications. PLoS One, 9(9), e108002. https://doi.org/10.1371/journal.pone.0108002.
Bijker, R., Duijts, S. F. A., Smith, S. N., de Wildt-Liesveld, R., Anema, J. R., & Regeer, B. J. (2017). Functional impairments and work-related outcomes in breast cancer survivors: A systematic review. Journal of Occupational Rehabilitation. https://doi.org/10.1007/s10926-017-9736-8.
Koch, L., Jansen, L., Herrmann, A., Stegmaier, C., Holleczek, B., Singer, S., et al. (2013). Quality of life in long-term breast cancer survivors—A 10-year longitudinal population-based study. Acta Oncologica, 52(6), 1119–1128. https://doi.org/10.3109/0284186X.2013.774461.
Arndt, V., Koch-Gallenkamp, L., Jansen, L., Bertram, H., Eberle, A., Holleczek, B., et al. (2017). Quality of life in long-term and very long-term cancer survivors versus population controls in Germany. Acta Oncologica, 56(2), 190–197. https://doi.org/10.1080/0284186X.2016.1266089.
Hsu, T., Ennis, M., Hood, N., Graham, M., & Goodwin, P. J. (2013). Quality of life in long-term breast cancer survivors. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 31(28), 3540–3548. https://doi.org/10.1200/JCO.2012.48.1903.
Muzzatti, B., Flaiban, C., Surbone, A., & Annunziata, M. A. (2015) Quality of life profile in Italian long-term cancer survivors. Quality of life research: An international journal of quality of life aspects of treatment. Care and Rehabilitation, 24(4), 959–967. https://doi.org/10.1007/s11136-014-0831-4.
Minton, O., & Stone, P. (2008). How common is fatigue in disease-free breast cancer survivors? A systematic review of the literature. Breast Cancer Research and Treatment, 112(1), 5–13. https://doi.org/10.1007/s10549-007-9831-1.
Schmidt, M. E., Wiskemann, J., Armbrust, P., Schneeweiss, A., Ulrich, C. M., & Steindorf, K. (2015). Effects of resistance exercise on fatigue and quality of life in breast cancer patients undergoing adjuvant chemotherapy: A randomized controlled trial. International Journal of Cancer, 137(2), 471–480. https://doi.org/10.1002/ijc.29383.
Steindorf, K., Schmidt, M. E., Klassen, O., Ulrich, C. M., Oelmann, J., Habermann, N., et al. (2014). Randomized controlled trial of resistance training in breast cancer patients receiving adjuvant radiotherapy: Results on cancer-related fatigue and quality of life. Annals of Oncology: Official Journal of the European Society for Medical Oncology/ESMO. https://doi.org/10.1093/annonc/mdu374.
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European organization for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376.
Fayers, P. M., Aaronson, N. K., Bjordal, K., Curran, D., Groenvold, M., Curran, D., et al. (2001). EORTC Scoring Manual. 3rd edn. Brussels: European Organisation for Research and Treatment of Cancer. Report No.: 2-930064-16-1.
Waldmann, A., Schubert, D., & Katalinic, A. (2013). Normative data of the EORTC QLQ-C30 for the German population: A population-based survey. PLoS ONE, 8(9), e74149. https://doi.org/10.1371/journal.pone.0074149.
Fabrigar, L. R. W., Duane, T., MacCallum, R. C., & Strahan, E. J. (1999). Evaluating the use of exploratory factor analysis in psychological research. Psychological Methods, 4(3), 272–299.
Ousmen, A., Conroy, T., Guillemin, F., Velten, M., Jolly, D., Mercier, M., et al. (2016). Impact of the occurrence of a response shift on the determination of the minimal important difference in a health-related quality of life score over time. Health and Quality of Life Outcomes, 14(1), 167. https://doi.org/10.1186/s12955-016-0569-5.
Joly, F., Giffard, B., Rigal, O., De Ruiter, M. B., Small, B. J., Dubois, M., et al. (2015). Impact of cancer and its treatments on cognitive function: Advances in research from the Paris International Cognition and Cancer Task Force Symposium and update since 2012. Journal of Pain and Symptom Management, 50(6), 830–841. https://doi.org/10.1016/j.jpainsymman.2015.06.019.
Wefel, J. S., Kesler, S. R., Noll, K. R., & Schagen, S. B. (2015). Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults. CA: A Cancer Journal for Clinicians, 65(2), 123–138. https://doi.org/10.3322/caac.21258.
Treanor, C. J., McMenamin, U. C., O’Neill, R. F., Cardwell, C. R., Clarke, M. J., Cantwell, M., et al. (2016). Non-pharmacological interventions for cognitive impairment due to systemic cancer treatment. The Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD011325.
Lowery-Allison, A. E., Passik, S. D., Cribbet, M. R., Reinsel, R. A., O’Sullivan, B., Norton, L., et al. (2017) Sleep problems in breast cancer survivors 1-10 years posttreatment. Palliative & Supportive Care. https://doi.org/10.1017/S1478951517000311.
Jim, H. S., Jacobsen, P. B., Phillips, K. M., Wenham, R. M., Roberts, W., & Small, B. J. (2013). Lagged relationships among sleep disturbance, fatigue, and depressed mood during chemotherapy. Health Psychology, 32(7), 768–774. https://doi.org/10.1037/a0031322.
Fortier-Brochu, E., & Morin, C. M. (2014). Cognitive impairment in individuals with insomnia: Clinical significance and correlates. Sleep, 37(11), 1787–1798. https://doi.org/10.5665/sleep.4172.
Lim, J., & Dinges, D. F. (2010). A meta-analysis of the impact of short-term sleep deprivation on cognitive variables. Psychological Bulletin, 136(3), 375–389. https://doi.org/10.1037/a0018883.
Henneghan, A., Stuifbergen, A., Becker, H., Kesler, S., & King, E. (2017). Modifiable correlates of perceived cognitive function in breast cancer survivors up to 10 years after chemotherapy completion. Journal of Cancer Survivorship: Research and Practice. https://doi.org/10.1007/s11764-017-0661-9.
Trudel-Fitzgerald, C., Zhou, E. S., Poole, E. M., Zhang, X., Michels, K. B., Eliassen, A. H., et al. (2017). Sleep and survival among women with breast cancer: 30 years of follow-up within the Nurses’ Health Study. British Journal of Cancer, 116(9), 1239–1246. https://doi.org/10.1038/bjc.2017.85.
Steindorf, K., Wiskemann, J., Ulrich, C. M., & Schmidt, M. E. (2017). Effects of exercise on sleep problems in breast cancer patients receiving radiotherapy: A randomized clinical trial. Breast Cancer Research and Treatment, 162, 489–499. https://doi.org/10.1007/s10549-017-4141-8.
Courneya, K. S., Segal, R. J., Mackey, J. R., Gelmon, K., Friedenreich, C. M., Yasui, Y., et al. (2014). Effects of exercise dose and type on sleep quality in breast cancer patients receiving chemotherapy: A multicenter randomized trial. Breast Cancer Research and Treatment, 144(2), 361–369. https://doi.org/10.1007/s10549-014-2883-0.
Berger, A. M., & Mooney, K. (2016). Dissemination and implementation of guidelines for cancer-related fatigue. Journal of the National Comprehensive Cancer Network: JNCCN, 14(11), 1336–1338.
Berger, A. M., Mooney, K., Alvarez-Perez, A., Breitbart, W. S., Carpenter, K. M., Cella, D., et al. (2015). Cancer-related fatigue, version 2.2015. Journal of the National Comprehensive Cancer Network: JNCCN, 13(8), 1012–1039.
Ho, S. Y., Rohan, K. J., Parent, J., Tager, F. A., & McKinley, P. S. (2015). A longitudinal study of depression, fatigue, and sleep disturbances as a symptom cluster in women with breast cancer. Journal of Pain and Symptom Management, 49(4), 707–715. https://doi.org/10.1016/j.jpainsymman.2014.09.009.
Donovan, K. A., & Jacobsen, P. B. (2007). Fatigue, depression, and insomnia: Evidence for a symptom cluster in cancer. Seminars in Oncology Nursing, 23(2), 127–135. https://doi.org/10.1016/j.soncn.2007.01.004.
Barsevick, A. M. (2007). The elusive concept of the symptom cluster. Oncology Nursing Forum, 34(5), 971–980. https://doi.org/10.1188/07.ONF.971-980.
Gupta, P., Sturdee, D. W., Palin, S. L., Majumder, K., Fear, R., Marshall, T., et al. (2006). Menopausal symptoms in women treated for breast cancer: The prevalence and severity of symptoms and their perceived effects on quality of life. Climacteric, 9(1), 49–58. https://doi.org/10.1080/13697130500487224.
Davis, S. R., Panjari, M., Robinson, P. J., Fradkin, P., & Bell, R. J. (2014). Menopausal symptoms in breast cancer survivors nearly 6 years after diagnosis. Menopause, 21(10), 1075–1081. https://doi.org/10.1097/GME.0000000000000219.
Hill, E. K., Sandbo, S., Abramsohn, E., Makelarski, J., Wroblewski, K., Wenrich, E. R., et al. (2011). Assessing gynecologic and breast cancer survivors’ sexual health care needs. Cancer, 117(12), 2643–2651. https://doi.org/10.1002/cncr.25832.
Stabile, C., Goldfarb, S., Baser, R. E., Goldfrank, D. J., Abu-Rustum, N. R., Barakat, R. R., et al. (2017). Sexual health needs and educational intervention preferences for women with cancer. Breast Cancer Research and Treatment, 165(1), 77–84. https://doi.org/10.1007/s10549-017-4305-6.
Santen, R. J., Stuenkel, C. A., Davis, S. R., Pinkerton, J. V., Gompel, A., & Lumsden, M. A. (2017). Managing menopausal symptoms and associated clinical issues in breast cancer survivors. The Journal of Clinical Endocrinology and Metabolism, 102(10), 3647–3661. https://doi.org/10.1210/jc.2017-01138.
Klassen, O., Schmidt, M. E., Scharhag-Rosenberger, F., Sorkin, M., Ulrich, C. M., Schneeweiss, A., et al. (2014). Cardiorespiratory fitness in breast cancer patients undergoing adjuvant therapy. Acta Oncologica, 53(10), 1356–1365. https://doi.org/10.3109/0284186X.2014.899435.
Klassen, O., Schmidt, M. E., Ulrich, C. M., Schneeweiss, A., Potthoff, K., Steindorf, K., et al. (2017). Muscle strength in breast cancer patients receiving different treatment regimes. Journal of Cachexia, Sarcopenia and Muscle, 8(2), 305–316. https://doi.org/10.1002/jcsm.12165.
Lakoski, S. G., Barlow, C. E., Koelwyn, G. J., Hornsby, W. E., Hernandez, J., Defina, L. F., et al. (2013). The influence of adjuvant therapy on cardiorespiratory fitness in early-stage breast cancer seven years after diagnosis: The Cooper Center Longitudinal Study. Breast Cancer Research and Treatment, 138(3), 909–916.
Beckwee, D., Leysen, L., Meuwis, K., & Adriaenssens, N. (2017). Prevalence of aromatase inhibitor-induced arthralgia in breast cancer: A systematic review and meta-analysis. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer, 25(5), 1673–1686. https://doi.org/10.1007/s00520-017-3613-z.
Hershman, D. L., Shao, T., Kushi, L. H., Buono, D., Tsai, W. Y., Fehrenbacher, L., et al. (2011). Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Research and Treatment, 126(2), 529–537. https://doi.org/10.1007/s10549-010-1132-4.
Yang, G. S., Kim, H. J., Griffith, K. A., Zhu, S., Dorsey, S. G., & Renn, C. L. (2017). Interventions for the treatment of aromatase inhibitor-associated arthralgia in breast cancer survivors: A systematic review and meta-analysis. Cancer Nursing, 40(4), E26–E41. https://doi.org/10.1097/NCC.0000000000000409.
Irwin, M. L., Cartmel, B., Gross, C. P., Ercolano, E., Li, F., Yao, X., et al. (2015). Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 33(10), 1104–1111. https://doi.org/10.1200/JCO.2014.57.1547.
Brewer, J. R., Morrison, G., Dolan, M. E., & Fleming, G. F. (2016). Chemotherapy-induced peripheral neuropathy: Current status and progress. Gynecologic Oncology, 140(1), 176–183. https://doi.org/10.1016/j.ygyno.2015.11.011.
Jiralerspong, S., & Goodwin, P. J. (2016). Obesity and breast cancer prognosis: Evidence, challenges, and opportunities. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 34(35), 4203–4216. https://doi.org/10.1200/JCO.2016.68.4480.
Steindorf, K., Schmidt, M. E., Klassen, O., Oelmann, J., Hof, H., Debus, J., et al. (2014). Progressive resistance training in breast cancer patients undergoing adjuvant radiotherapy: Results of a randomized trial. Medicine and Science in Sports and Exercise, 46(5S), 368–369.
Schmidt, M. E., Wiskemann, J., Ulrich, C. M., Schneeweiss, A., & Steindorf, K. (2017). Self-reported physical activity behavior of breast cancer survivors during and after adjuvant therapy: 12 months follow-up of two randomized exercise intervention trials. Acta Oncologica, 56(4), 618–627. https://doi.org/10.1080/0284186X.2016.1275776.
Schmidt, M. E., Wiskemann, J., Schneeweiss, A., Potthoff, K., Ulrich, C. M., & Steindorf, K. (2017). Determinants of physical, affective, and cognitive fatigue during breast cancer therapy and 12 months follow-up. International Journal of Cancer. https://doi.org/10.1002/ijc.31138.
Acknowledgements
The authors thank Sabine Holzmeier for data management of the 5-year follow-up, and the teams that had conducted the parent studies (BEATE and BEST).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Schmidt, M.E., Wiskemann, J. & Steindorf, K. Quality of life, problems, and needs of disease-free breast cancer survivors 5 years after diagnosis. Qual Life Res 27, 2077–2086 (2018). https://doi.org/10.1007/s11136-018-1866-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-018-1866-8